User menu

Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia

Bibliographic reference Orlando, Giuseppe ; Lerut, Jan ; Tariciotti, L. ; Manzia, T. M. ; Gravante, G. ; et. al. Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. In: Transplant Infectious Disease, Vol. 12, no. 1, p. 11-5 (2010)
Permanent URL http://hdl.handle.net/2078.1/34225
  1. 1.  Kovacs JA , Gill VJ , Meshnick S , Masur H. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001; 286: 2450-2460.
  2. 2.  Kramer MR , Stoehr C , Lewiston NJ , Starnes VA , Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation - how effective and for how long? Transplantation 1992; 53: 586-589.
  3. 3.  Gordon SM , LaRosa SP , Kalmadi S , et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999; 28: 240-246.
  4. 4.  Fishman JA. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis 2001; 33: 1397-1405.
  5. 5.  Olsen SL , Renlund DG , O'Connell JB , et al. Prevention of Pneumocystis carinii pneumonia in cardiac transplant recipients by trimethoprim sulfamethoxazole. Transplantation 1993; 56: 359-362.
  6. 6.  Hughes WT , Kuhn S , Chaudhary S , et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 297: 1419-1426.
  7. 7.  Hughes WT , Rivera GK , Schell MJ , Thornton D , Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987; 316: 1627-1632.
  8. 8.  Dummer JS. Pneumocystis carinii infections in transplant recipients. Semin Respir Infect 1990; 5: 50-57.
  9. 9.  Higgins RM , Bloom SL , Hopkin JM , Morris PJ. The risks and benefits of low-dose cotrimoxazole prophylaxis for Pneumocystis pneumonia in renal transplantation. Transplantation 1989; 47: 558-560.
  10. 10.  Torre-Cisneros J , de la Mata M , Lopez-Cillero P , Sanchez-Guijo P , Mino G , Pera C. Effectiveness of daily low-dose cotrimoxazole prophylaxis for Pneumocystis carinii pneumonia in liver transplantation - an open clinical trial. Transplantation 1996; 62: 1519-1521.
  11. 11.  Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
  12. 12.  Almaslmani M , Derbala MF , Albozom I , Khattab M , Chacko K , Alani A. Bronchiolitis obliterans organizing pneumonia associated with Pneumocystis jiroveci infection in orthotopic liver transplantation. Transpl Infect Dis 2008; 10: 339-342.
  13. 13.  Trotter JF , Levi M , Steinberg T , Lancaster J. Absence of Pneumocystis jiroveci pneumonia in liver transplantation recipients receiving short-term (3-month) prophylaxis. Transpl Infect Dis 2008; 10: 369-371.
  14. 14.  Tisone G , Angelico M , Palmieri G , et al. A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation. Transplantation 1999; 67: 1308-1313.
  15. 15.  Tisone G , Orlando G , Vennarecci G , et al. Spontaneous resolution of severe acute rejection in liver transplantation. Transplant Proc 1999; 31: 3164-3166.
  16. 16.  Humar A , Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262-274.
  17. 17.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
  18. 18.  Baiocchi L , Angelico M , De Luca L , et al. Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. Transpl Int 2006; 19: 389-395.
  19. 19.  Martínez-Llordella M , Lozano JJ , Puig-Pey I , et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008, 118 (8): 2845-2857.
  20. 20.  Martínez-Llordella M , Puig-Pey I , Orlando G , et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7: 309-319.
  21. 21.  Tisone G , Orlando G , Cardillo A , et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol 2006; 44: 702-709.
  22. 22.  Orlando G , Manzia T , Baiocchi L , Sanchez-Fuego A , Angelico M , Tisone G . The Tor Vergata weaning off immunosuppression trial in stable HCV liver transplant patients: the updated follow up at 78 months. Transpl Immunol 2008; 20: 43-47.
  23. 23.  Lerut J , Bonaccorsi-Riani E , Finet P , Gianello P. Minimization of steroids in liver transplantation. Transpl Int 2009; 22: 2-19.
  24. 24.  Orlando G , Soker S , Wood KJ. Operational tolerance after liver transplantation. J Hepatol 2009; 50: 1247-1257.
  25. 25.  Sanchez-Fueyo A , Strom TB. Immunological tolerance and liver transplantation. J Hepatol 2004; 41: 698-705.
  26. 26.  Stephenson GR , Moretti EW , El-Moalem H , Clavien PA , Tuttle-Newhall JE. Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation 2001; 72: 666-670.
  27. 27.  Lerut J , Mathys J , Verbaandert C , et al. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomised, double-blind, placebo-controlled study. Ann Surg 2008; 248: 956-967.
  28. 28.  Karam V , Gasquet I , Delvart V , et al. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation 2003; 76: 1699-1704.
  29. WHO, WHO Scientific Working Group on Monitoring and Management of Bacterial Resistance to Antimicrobial Agents (1994)
  30. 30.  Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
  31. 31.  Tacconelli E , De Angelis G , Cataldo MA , Pozzi E , Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008; 61: 26-38.